- Ownership
- Activity
LGND Stock Ownership Activity
LIGAND PHARMACEUTICALS 13F holders
No value investing guru has made any change to the LIGAND PHARMACEUTICALS (LGND) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying LGND now?
According to the latest SEC filing(s) LIGAND PHARMACEUTICALS (LGND) has not been purchased by any super investor.
To see more about who is investing in LIGAND PHARMACEUTICALS (LGND), please go to the LGND ownership page.
2025 Q3
(1 result)
Current price: $234.40
106.19%
Reported price*: $113.68
2025 Q2
(1 result)
Current price: $234.40
106.19%
Reported price*: $113.68
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.